Ibrx shareholder alert: jakubowitz law reminds immunitybio shareholders of a lead plaintiff deadline of august 29, 2023

New york , aug. 4, 2023 /prnewswire/ -- jakubowitz law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of immunitybio, inc. (nasdaq: ibrx). to receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/immunitybio-class-action-loss-submission-form/?id=42953&from=4 the lawsuit seeks to recover losses for shareholders who purchased immunitybio between may 23, 2022 and may 10, 2023.
IBRX Ratings Summary
IBRX Quant Ranking